Nuestra página de facturación está certificada por:
Long-term benefits of ADHD drugs in kids are uncertain - ConsumerReports.org (blog)
Long-term benefits of ADHD drugs in kids are uncertainConsumerReports.
Lilly Reports Solid Start to the Year With First-Quarter 2012 Results, Raises ... - MarketWatch (press release)
Lilly Reports Solid Start to the Year With First-Quarter 2012 Results, Raises .
不專心坐不住 恐患注意力不足過動症 - yam天空新聞
不專心坐不住 恐患注意力不足過動症yam天空新聞根據衛生署指出,目前核准用以治療ADHD的藥物是(一)中樞神經興奮劑:Methylphenidate,MPH(短效型MPH,Ritalin;長效型MPH,Concerta),國際上已使用於治療ADHD超過50年了,衛生署也核准MPH治療ADHD長達數十年了;(二)非中樞神經興奮劑:Atomoxetine(思銳)。y más ».
Retail prices of 1000 medicines to fall under new reimbursement list - Pharma Poland News (subscription)
Pharma Poland News (subscription)Retail prices of 1000 medicines to fall under new reimbursement listPharma Poland News (subscription)Also, it again includes atomoxetine as indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged six and older and teens.